Ethnic or racial differences in breast cancer (BC) survival outcomes have been reported, but
current data are largely restricted to comparisons between African Americans and non …

Black women in the US have significantly higher breast cancer mortality than White women.
Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women …

Persistent disparities in the burden of breast cancer between African Americans and White
Americans have been documented over many decades. Features characterizing breast …

Randomized, clinical trials have established the efficacy of screening mammography in
improving survival from breast cancer for women through detection of early, asymptomatic …

Objective: The aim of this study was to evaluate the association between neighborhood
disadvantage and Oncotype DX score, a surrogate for tumor biology, among a national …

PURPOSE Despite effective early-detection approaches and innovative treatments, Black
women in the United States have higher breast cancer mortality rates compared with White …

PURPOSE Genomic tests, such as the Oncotype Dx 21-gene and Prosigna risk of
recurrence (ROR-P) assay, are commonly used for breast cancer prognostication. Emerging …

Background The objective of this study was to determine the influence of race/ethnicity and
socioeconomic status (SES) on breast cancer outcomes. Methods A retrospective analysis …

Abstract Purpose The Oncotype DX Recurrence Score (RS) is a widely used prognostic tool
for estrogen receptor-positive breast cancer patients. Multiple surrogate models can predict …

Importance Disproportionately aggressive tumor biology among non-Hispanic Black women
with early-stage, estrogen receptor (ER)–positive breast cancer contributes to racial …